PhRMA Dismisses Lawsuit Challenging 340B ADR Rule

A Maryland federal judge granted PhRMA's request to dismiss its challenge to the government's 340B ADR process.
A Maryland federal judge recently granted an influential drug industry trade group’s request to dismiss its 2021 lawsuit challenging a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Sues HHS, HRSA to Implement Expansive 340B Rebate for All Products and Covered Entity Types

A California-based hospital sued HHS Jan. 15 alleging it "unlawfully" prevented it from accessing the 340B program for six months.
Eli Lilly on Thursday sued the federal government to implement a sweeping 340B rebate model that would apply to all [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Lawsuit to Test Trump Administration’s Stance on 340B Rebates

J&J sued HRSA on Nov. 12 for threatening enforcement action that led the drugmaker to withdraw its 340B rebate proposal.
Johnson & Johnson’s (J&J’s) lawsuit challenging the federal government’s opposition to 340B rebates will test whether the Trump administration is [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Stakeholders Prepare for New Senate with Two Key GOP Players with Vast Differences on 340B

Incoming Senate Majority Leader John Thune (R-S.D.), left, and HELP Committee Chairperson Bill Cassidy (R-La.), right, have contrasting stances on the 340B program. (Photos courtesy: Thune, Cassidy's Senate offices.)
With one outspoken critic of the 340B program and one key supporter set to hold influential positions in the new [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Major Change from Previous Tenure, President-Elect Trump Selects Vaccine Skeptic RFK Jr. as HHS Secretary

RFK Jr.
President-elect Donald Trump (R) nominated Robert F. Kennedy, Jr. for U.S. Department of Health and Human Services (HHS) Secretary.
In an 180-degree change from his first term in the White House, President-elect Donald Trump (R) late Thursday nominated Robert [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Mississippi, West Virginia, Missouri

Key briefs were filed this week in state contract pharmacy litigation in Mississippi, West Virginia and Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Critic Cassidy to Chair Key Senate Committee

U.S. Sen. Bill Cassidy (R-La.) will chair the Senate Health, Education, Labor and Pensions Committee in the 119th Congress.
U.S. Sen. Bill Cassidy, a Louisiana Republican and outspoken critic of the 340B program, will lead the Senate committee tasked [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GOP Retains Control of U.S. House to Put Republicans in Charge of Congress, White House

Republicans reportedly clinched control of the U.S. House of Representatives, though the leader of a committee with jurisdiction over 340B has not yet been decided.
Republicans reportedly clinched control of the U.S. House of Representatives on Wednesday, officially winning key races that put them over [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate GOP Selects Thune, a 340B Champion, as Next Majority Leader Despite Pushback from Trump Allies

Senate Republicans on Wednesday selected U.S. Sen. John Thune (R-S.D.) as their next majority leader.
One week after clinching control of the U.S. Senate, GOP senators elected U.S. Sen. John Thune (R-S.D.), the chamber’s second-ranking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New CMS Rule Mulls Data Repository for 340B Claims in 2026, But Implementation Challenges Loom

The second group of high-cost prescription drugs chosen for Medicare price negotiations were announced last week just ahead of former President Joe Biden's departure from the White House.
Federal regulators are exploring a data repository to identify 340B claims to exclude from certain Medicare inflation rebates in 2026 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live